Logo image of BWIN

BALDWIN INSURANCE GROUP INC/ (BWIN) Stock Fundamental Analysis

NASDAQ:BWIN - Nasdaq - US05589G1022 - Common Stock - Currency: USD

38  -0.1 (-0.26%)

After market: 38 0 (0%)

Fundamental Rating

3

Overall BWIN gets a fundamental rating of 3 out of 10. We evaluated BWIN against 143 industry peers in the Insurance industry. BWIN may be in some trouble as it scores bad on both profitability and health. BWIN shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year BWIN was profitable.
In the past year BWIN had a positive cash flow from operations.
BWIN had negative earnings in each of the past 5 years.
In multiple years BWIN reported negative operating cash flow during the last 5 years.
BWIN Yearly Net Income VS EBIT VS OCF VS FCFBWIN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 50M -50M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.69%, BWIN is doing worse than 86.01% of the companies in the same industry.
BWIN's Return On Equity of -4.20% is on the low side compared to the rest of the industry. BWIN is outperformed by 86.01% of its industry peers.
BWIN has a Return On Invested Capital of 1.93%. This is comparable to the rest of the industry: BWIN outperforms 48.95% of its industry peers.
Industry RankSector Rank
ROA -0.69%
ROE -4.2%
ROIC 1.93%
ROA(3y)-1.49%
ROA(5y)N/A
ROE(3y)-9.05%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BWIN Yearly ROA, ROE, ROICBWIN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 0 -5 -10 -15

1.3 Margins

Looking at the Operating Margin, with a value of 4.37%, BWIN is doing worse than 80.42% of the companies in the same industry.
BWIN has a Gross Margin of 25.70%. This is amongst the best in the industry. BWIN outperforms 88.11% of its industry peers.
BWIN's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.37%
PM (TTM) N/A
GM 25.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.47%
GM growth 5YN/A
BWIN Yearly Profit, Operating, Gross MarginsBWIN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 0 10 20

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BWIN is destroying value.
BWIN has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, BWIN has a worse debt to assets ratio.
BWIN Yearly Shares OutstandingBWIN Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 20M 40M 60M 80M 100M
BWIN Yearly Total Debt VS Total AssetsBWIN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

BWIN has an Altman-Z score of 1.27. This is a bad value and indicates that BWIN is not financially healthy and even has some risk of bankruptcy.
With an excellent Altman-Z score value of 1.27, BWIN belongs to the best of the industry, outperforming 82.52% of the companies in the same industry.
The Debt to FCF ratio of BWIN is 23.12, which is on the high side as it means it would take BWIN, 23.12 years of fcf income to pay off all of its debts.
BWIN has a Debt to FCF ratio of 23.12. This is in the lower half of the industry: BWIN underperforms 78.32% of its industry peers.
A Debt/Equity ratio of 2.40 is on the high side and indicates that BWIN has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 2.40, BWIN is doing worse than 92.31% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.4
Debt/FCF 23.12
Altman-Z 1.27
ROIC/WACC0.23
WACC8.52%
BWIN Yearly LT Debt VS Equity VS FCFBWIN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

BWIN has a Current Ratio of 0.97. This is a bad value and indicates that BWIN is not financially healthy enough and could expect problems in meeting its short term obligations.
BWIN's Current ratio of 0.97 is fine compared to the rest of the industry. BWIN outperforms 77.62% of its industry peers.
BWIN has a Quick Ratio of 0.97. This is a bad value and indicates that BWIN is not financially healthy enough and could expect problems in meeting its short term obligations.
BWIN has a Quick ratio of 0.97. This is in the better half of the industry: BWIN outperforms 77.62% of its industry peers.
Industry RankSector Rank
Current Ratio 0.97
Quick Ratio 0.97
BWIN Yearly Current Assets VS Current LiabilitesBWIN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 200M 400M 600M 800M 1B

8

3. Growth

3.1 Past

BWIN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.19%, which is quite impressive.
Measured over the past years, BWIN shows a very strong growth in Earnings Per Share. The EPS has been growing by 23.83% on average per year.
The Revenue has grown by 13.99% in the past year. This is quite good.
BWIN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 34.78% yearly.
EPS 1Y (TTM)26.19%
EPS 3Y23.83%
EPS 5YN/A
EPS Q2Q%16.07%
Revenue 1Y (TTM)13.99%
Revenue growth 3Y34.78%
Revenue growth 5YN/A
Sales Q2Q%8.69%

3.2 Future

BWIN is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 24.47% yearly.
The Revenue is expected to grow by 14.05% on average over the next years. This is quite good.
EPS Next Y22.21%
EPS Next 2Y24.1%
EPS Next 3Y24.47%
EPS Next 5YN/A
Revenue Next Year10.91%
Revenue Next 2Y12.41%
Revenue Next 3Y14.23%
Revenue Next 5Y14.05%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
BWIN Yearly Revenue VS EstimatesBWIN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 500M 1B 1.5B 2B 2.5B
BWIN Yearly EPS VS EstimatesBWIN Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2 2.5

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 23.90, BWIN is valued on the expensive side.
BWIN's Price/Earnings ratio is a bit more expensive when compared to the industry. BWIN is more expensive than 69.93% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 25.82. BWIN is around the same levels.
Based on the Price/Forward Earnings ratio of 16.45, the valuation of BWIN can be described as correct.
65.73% of the companies in the same industry are cheaper than BWIN, based on the Price/Forward Earnings ratio.
BWIN is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 23.9
Fwd PE 16.45
BWIN Price Earnings VS Forward Price EarningsBWIN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BWIN is valued a bit more expensive than 68.53% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BWIN is valued expensively inside the industry as 81.12% of the companies are valued cheaper.
Industry RankSector Rank
P/FCF 74.01
EV/EBITDA 34.04
BWIN Per share dataBWIN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 -10 -15

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as BWIN's earnings are expected to grow with 24.47% in the coming years.
PEG (NY)1.08
PEG (5Y)N/A
EPS Next 2Y24.1%
EPS Next 3Y24.47%

0

5. Dividend

5.1 Amount

BWIN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BALDWIN INSURANCE GROUP INC/

NASDAQ:BWIN (5/23/2025, 9:17:19 PM)

After market: 38 0 (0%)

38

-0.1 (-0.26%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)05-06 2025-05-06/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners101.72%
Inst Owner ChangeN/A
Ins Owners4.07%
Ins Owner Change-2.72%
Market Cap4.50B
Analysts78.75
Price Target49.83 (31.13%)
Short Float %7.56%
Short Ratio7.8
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-0.61%
Min EPS beat(2)-5.25%
Max EPS beat(2)4.03%
EPS beat(4)3
Avg EPS beat(4)1.27%
Min EPS beat(4)-5.25%
Max EPS beat(4)5.02%
EPS beat(8)6
Avg EPS beat(8)3.74%
EPS beat(12)8
Avg EPS beat(12)3.15%
EPS beat(16)11
Avg EPS beat(16)6.4%
Revenue beat(2)0
Avg Revenue beat(2)-2.66%
Min Revenue beat(2)-4.36%
Max Revenue beat(2)-0.97%
Revenue beat(4)0
Avg Revenue beat(4)-1.64%
Min Revenue beat(4)-4.36%
Max Revenue beat(4)-0.45%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.87%
PT rev (3m)-1.63%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-2.91%
EPS NY rev (1m)-0.68%
EPS NY rev (3m)-5.28%
Revenue NQ rev (1m)0.11%
Revenue NQ rev (3m)-2.5%
Revenue NY rev (1m)-0.32%
Revenue NY rev (3m)-1.94%
Valuation
Industry RankSector Rank
PE 23.9
Fwd PE 16.45
P/S 3.24
P/FCF 74.01
P/OCF 44.08
P/B 7.72
P/tB N/A
EV/EBITDA 34.04
EPS(TTM)1.59
EY4.18%
EPS(NY)2.31
Fwd EY6.08%
FCF(TTM)0.51
FCFY1.35%
OCF(TTM)0.86
OCFY2.27%
SpS11.72
BVpS4.92
TBVpS-15.04
PEG (NY)1.08
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.69%
ROE -4.2%
ROCE 2.45%
ROIC 1.93%
ROICexc 2.06%
ROICexgc N/A
OM 4.37%
PM (TTM) N/A
GM 25.7%
FCFM 4.38%
ROA(3y)-1.49%
ROA(5y)N/A
ROE(3y)-9.05%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-4.47%
GM growth 5YN/A
F-Score6
Asset Turnover0.39
Health
Industry RankSector Rank
Debt/Equity 2.4
Debt/FCF 23.12
Debt/EBITDA 8.24
Cap/Depr 37.93%
Cap/Sales 2.97%
Interest Coverage 0.54
Cash Conversion 60.24%
Profit Quality N/A
Current Ratio 0.97
Quick Ratio 0.97
Altman-Z 1.27
F-Score6
WACC8.52%
ROIC/WACC0.23
Cap/Depr(3y)30.38%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.5%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.19%
EPS 3Y23.83%
EPS 5YN/A
EPS Q2Q%16.07%
EPS Next Y22.21%
EPS Next 2Y24.1%
EPS Next 3Y24.47%
EPS Next 5YN/A
Revenue 1Y (TTM)13.99%
Revenue growth 3Y34.78%
Revenue growth 5YN/A
Sales Q2Q%8.69%
Revenue Next Year10.91%
Revenue Next 2Y12.41%
Revenue Next 3Y14.23%
Revenue Next 5Y14.05%
EBIT growth 1Y242.53%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year149.47%
EBIT Next 3Y54.68%
EBIT Next 5Y36.26%
FCF growth 1Y187.63%
FCF growth 3Y24.41%
FCF growth 5YN/A
OCF growth 1Y128.81%
OCF growth 3Y36.54%
OCF growth 5YN/A